⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL6942259 | 0.98 | CTSD (0.52) | — | |
| SCHEMBL7102012 | 0.86 | CTSD (0.50) | — | |
| Hydrochloric Acid SCHEMBL27456451 | 0.85 | CTSD (0.45) | — | |
| Hydrochloric Acid SCHEMBL742050 | 0.84 | CTSD (0.48) | — | |
| SCHEMBL406688 | 0.84 | CTSD (0.48) | — | |
| SCHEMBL10153020 | 0.83 | — | — | |
| SCHEMBL11573513 | 0.82 | ALDH1A1 (0.50) | — | |
| SCHEMBL12722970 | 0.81 | — | — | |
| SCHEMBL24116326 | 0.79 | CTSD (0.48) | — | |
| SCHEMBL18392616 | 0.79 | CTSD (0.48) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 55 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110713583-A | In-situ synthesis method of polylactic acid nucleating agent | 西南大学 | 2020-01-21 | — | — | CN | claimed |
| EP-2069321-A1 | NOVEL BENZOFURAN TYPE DERIVATIVES, A COMPOSITION COMPRISING THE SAME FOR TREATING OR PREVENTING COGNITIVE DYSFUNCTION AND THE USE THEREOF | Digital Biotech Co., Ltd. (KR) | 2009-06-17 | — | — | EP | claimed |
| WO-2008041826-A1 | NOVEL BENZOFURAN TYPE DERIVATIVES, A COMPOSITION COMPRISING THE SAME FOR TREATING OR PREVENTING COGNITIVE DYSFUNCTION AND THE USE THEREOF | DIGITAL BIOTECH CO., LTD (KR) | 2008-04-10 | — | — | WO | claimed |
| CN-110713583-A | In-situ synthesis method of polylactic acid nucleating agent | 西南大学 | 2020-01-21 | — | — | CN | disclosed |
| EP-2957587-B1 | METHOD FOR PRODUCING RUBBER COMPOSITION, AND RUBBER COMPOSITION | BRIDGESTONE CORP (JP) | 2018-12-26 | — | — | EP | disclosed |
| CN-106349156-B | It can be used as the pyridine -2- amides of CB2 agonist | 霍夫曼-拉罗奇有限公司 | 2018-12-11 | — | — | CN | disclosed |
| US-10087292-B2 | Method for producing rubber composition, and rubber composition | BRIDGESTONE CORPORATION (JP) | 2018-10-02 | — | — | US | disclosed |
| EP-3196232-B1 | METHOD FOR MANUFACTURING RUBBER COMPOSITION, AND RUBBER COMPOSITION | BRIDGESTONE CORP (JP) | 2018-07-04 | — | — | EP | disclosed |
| EP-3029461-B1 | HAPTENS, HAPTEN CONJUGATES, COMPOSITIONS THEREOF AND METHOD FOR THEIR PREPARATION AND USE | VENTANA MED SYST INC (US) | 2017-12-20 | — | — | EP | disclosed |
| US-20170267818-A1 | METHOD FOR PRODUCING RUBBER COMPOSITION, AND RUBBER COMPOSITION | BRIDGESTONE CORPORATION (JP) | 2017-09-21 | — | — | US | disclosed |
| EP-3196232-A1 | METHOD FOR MANUFACTURING RUBBER COMPOSITION, AND RUBBER COMPOSITION | Bridgestone Corporation (JP) | 2017-07-26 | — | — | EP | disclosed |
| EP-0934291-A4 | — | SMITHKLINE BEECHAM CORP (US) | 1999-08-11 | — | — | EP | disclosed |
| EP-0934291-A1 | PROTEASE INHIBITORS | SMITHKLINE BEECHAM CORPORATION (US) | 1999-08-11 | — | — | EP | disclosed |
| EP-0527851-B1 | 1H-SUBSTITUTED-1,2,4-TRIAZOLE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS | SEARLE & CO (US) | 1998-12-23 | — | — | EP | disclosed |
| WO-1997016433-A1 | PROTEASE INHIBITORS | SMITHKLINE BEECHAM CORPORATION (US) | 1997-05-09 | — | — | WO | disclosed |
| US-5217985-A | RENAL-SELECTIVE BIPHENYLALKYL 1H-SUBSTITUTED-1,2,4-TRIAZOLE ANGIOTENSIN II ANTAGONISTS FOR TREATMENT OF HYPERTENSION | G. D. SEARLE & CO. (US) | 1993-06-08 | — | — | US | disclosed |
| EP-0527851-A1 | 1H-SUBSTITUTED-1,2,4-TRIAZOLE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS | G.D. SEARLE & CO. (US) | 1993-02-24 | — | — | EP | disclosed |
| US-5098920-A | Hypotensive agents and treatment of congestive heart failure | G. D. SEARLE & CO. (US) | 1992-03-24 | — | — | US | disclosed |
| WO-1992004335-A2 | RENAL-SELECTIVE BIPHENYLALKYL 1H-SUBSTITUTED-1,2,4-TRIAZOLE ANGIOTENSIN II ANTAGONISTS FOR TREATMENT OF HYPERTENSION | G.D. SEARLE & CO. (US) | 1992-03-19 | — | — | WO | disclosed |
| WO-1991017148-A1 | 1H-SUBSTITUTED-1,2,4-TRIAZOLE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS | G.D. SEARLE & CO. (US) | 1991-11-14 | — | — | WO | disclosed |